Recombinant Human Collagen Type I / COL1

Recombinant Human Collagen Type I / COL1

Recombinant Human Collagen Type I / COL1
Recombinant Human Collagen Type I/COL1

General Information

  • Product Name: Recombinant Human Collagen Type I / COL1
  • Catalog: RHC-I-001
  • Purity: ≥ 95% within Alpha, Beta & Gamma
  • Applications: Suitable for biomedical research including coating & 3D cell culture

Description

This recombinant human collagen type I / COL1 is available as full-chain or single chain molecules. Its synthesis and assembly require a multitude of genes and post-translational modifications which gives a more native human structure. The triple-helical collagens made by recombinant technology have the same amino acid sequence as human tissue-derived collagen. Furthermore, by achieving the equivalent extent of proline hydroxylation via co-expression of genes encoding prolyl hydroxylase with the collagen genes, one can produce collagens with a similar degree of stability as naturally occurring material.

The technical parameters of recombinant human collagen type I we supplied are as follows.

ItemsSpecification
FormLiquid
ColorColorless to Slight Yellow
Concentration as tested3.0 mg/mL ± 0.2
Electrophoretic Pattern≥ 95% Within Alpha, Beta & Gamma
≤ 5% Faster Than Alpha
pH7.0 ± 0.4
SDS PAGE GelTris Acetate
SDS PAGE StainCoomassie
Endotoxin Level (LAL)<0.2 EU/mL
SterilityNo Growth, 0.2μm Filtered
Solubility (Solvent)Water, PBS, Buffered Media.
Solubility (Turbidity)Clear
Storage Temperature2 – 8 °C
Expiry18 Months at 4°C
Case Study

Type I Collagen (COL1) Used for the Preparation of Gradient COL1/HAp Scaffolds for Tendon–Bone Interface Regeneration

A schematic diagram of the implantation of COL1 HAP biomimetic gradient scaffoldsDai, Xiaomei, et al. Biomaterials Advances 158 (2024): 213799.

Type I collagen (COL1), the primary structural protein in the extracellular matrix of tendons and bone, plays a pivotal role in the development of biomimetic materials for regenerative medicine. This study demonstrates the application of COL1 in the fabrication of a dual-phase, gradient composite scaffold designed to repair tendon–bone interface injuries—a clinical challenge due to the poor healing capacity of this transitional tissue.

A bilayer scaffold was engineered using COL1 and hydroxyapatite (HAp) powders, each blended with 10% gelatin and stirred separately to form uniform mixtures. The HAp layer was first cast and set at 4 °C, followed by the addition of the COL1 layer. After sequential cooling, the scaffold underwent chemical cross-linking using either Genipin, EDC/NHS, or a dual cross-linking strategy to enhance structural integrity and biological performance.

The optimal scaffold—dual cross-linked COL1/HAp—was loaded with human amniotic mesenchymal stem cells (hAMSCs) and implanted in a rat rotator cuff injury model. Micro-CT, histological, and biomechanical analyses confirmed superior healing, including aligned collagen fibers, fibrocartilage formation, and improved mechanical strength at 12 weeks post-implantation.

This work highlights the critical role of COL1 in scaffold design and provides a viable strategy for enhancing tendon–bone interface healing through biomimetic materials combined with stem cell therapy.

Type I Collagen Used for the Preparation of Gold Nanorod-Based Photothermal Therapeutics for Enhanced Wound Healing

Synergistic effect of gold nanorods coated with type I collagen and LED irradiation on wound healingPoomrattanangoon, Sasiprapa, and Dakrong Pissuwan. Nanoscale Advances 7.12 (2025): 3867-3880.

Type I collagen was employed as a functional coating for gold nanorods (GNRs) to create a bioactive nanocomposite (GNRs@C) with enhanced wound healing potential. In this study, the biocompatibility and cellular uptake of GNRs were significantly improved by surface conjugation with type I collagen, enabling effective interaction with human skin fibroblast (HSF) cells.

GNRs were synthesized via a seed-mediated growth method and subsequently modified with poly(sodium 4-styrenesulfonate) (PSS) before conjugation with type I collagen. The GNRs@C nanocomposite, when combined with light-emitting diode (LED) irradiation, significantly promoted HSF cell proliferation and accelerated scratch wound closure. Notably, full closure of scratched HSF monolayers was observed within 40 hours under GNRs@C and LED treatment, compared to untreated controls.

In addition to its wound-closure efficacy, the treatment substantially reduced inflammatory cytokines, including IL-6 and TNF-α, while upregulating key angiogenic and regenerative factors such as VEGF and bFGF. These biological responses underscore the synergistic effects of collagen-functionalized nanomaterials and photothermal stimulation in tissue repair.

This case highlights the critical role of type I collagen as a biologically active stabilizer and functional ligand in nanomaterial-based wound healing platforms, offering a promising strategy for non-invasive, photothermally enhanced regenerative therapies.

Collagen Type I Mimicking Peptide GFOGER Is Used for the Preparation of Supramolecular Hydrogels to Support Keratocyte Differentiation

Collagen type I mimicking peptide additives to functionalize synthetic supramolecular hydrogelsVrehen, Annika F., et al. Materials Today Bio 26 (2024): 101021.

Collagen type I is a critical structural protein in the human corneal stroma. In a recent study, two peptide analogues—UPy-GFOGER and UPy-DGEA—were synthesized to mimic collagen type I for incorporation into supramolecular hydrogels. The GFOGER sequence (GGG-GPP5-GFOGER-GPP5), rich in glycine-proline-proline (GPP) repeats, was designed to promote triple-helix formation, a hallmark of natural collagen. In contrast, DGEA (GCGDGEA) lacks this structural complexity.

The peptides were conjugated with ureido-pyrimidinone (UPy) moieties and embedded in a UPy-based hydrogel system composed of UPy-Glycine and UPy-PEG10K-UPy. These hydrogels were used to encapsulate primary human corneal keratocytes (PKs), enabling comparative assessment of peptide-induced bioactivity.

Structural analysis confirmed that UPy-GFOGER self-assembled into nanofibers with triple-helical superstructure, whereas UPy-DGEA remained structurally simple. Biologically, UPy-GFOGER hydrogels supported PK elongation and redifferentiation, indicating effective mimicry of native extracellular matrix cues. In contrast, UPy-DGEA led to minimal cell spreading, highlighting its limited biofunctionality.

This study demonstrates that collagen type I mimicking GFOGER peptide, when integrated into a supramolecular hydrogel, enables advanced 3D culture environments by promoting keratocyte differentiation. Its structured assembly and bioactivity underscore the importance of triple-helical motifs for replicating native collagen behavior in biomaterial design.

* Alfa Chemistry also provides recombinant human collagen type I in the form of powder.

Alfa Chemistry is a professional synthetic biology company that manufactures recombinant collagen and other high-value proteins at scale. Process of our recombinant collagens avoids the use of harsh solvents, enzymes, and other manufacturing steps to ensure protein structure is retained. For high quality products and more information, please feel free to contact us.

Possibilities are unlimited with Alfa Chemistry. Let's discuss your idea.

Please kindly note that our products and services are for research use only.